期刊文献+

环氧化酶-2及其抑制剂在疼痛治疗中的作用 被引量:3

下载PDF
导出
摘要 非甾体抗炎药(nonsteroidal anti-inflammatory drugs,NSAIDs)通过抑制前列腺素合成中的环氧化酶(cyclooxygenase,COX)、从而阻断花生四烯酸生成前列腺素,发挥镇痛抗炎的作用。但因其胃肠道、肾功能、心血管和血小板等方面的副作用, 限制了它的广泛使用。COX存在两种同分异构体,其中环氧化酶-2(COX-2)主要在损伤或炎症部位表达,并合成前列腺素类物质,由此推动了选择性COX-2抑制剂的研制。普遍认为它与传统的NSAIDs的镇痛抗炎性能相当,但副作用减少。目前,这种学说得到了广泛的认同,然而,COX-2抑制剂的应用还有待深入认识。
作者 高梅 钱燕宁
出处 《国外医学(麻醉学与复苏分册)》 2003年第4期250-253,共4页 Foreign Medical Sciences(Anesthesilolgy and Resuscitation)
  • 相关文献

参考文献20

  • 1Geba, Gregory D. Efficacy of rofecoxib, celecoxib, and acetaminopher in osteoarlhritis of knee: a randomized trial. JAMA, 2002,287(1):64-71.
  • 2Katz, Warren A. COX-2-selective inhibitors in the management of acute and peri-operative pain. Cleve Clin J Med,2002,69(suppll ):SI65-75.
  • 3Scheiman, James M. Outcomes studies of the gastrointestinal safety of COX-2 inhibitors. Clvev Clin J Med, 2002,69( suppll ) : SI40-46.
  • 4Konstam, Marvin A. Current perspective on the cardiovascular effects of coxibs. Cleve Clin J Med, 2002,69(suppll ) : SI47-52.
  • 5Peura, David A. Gastrointestinal safety and tolerability of nonselective NSAIDs and COX-2-selective inhibitors. Cleve Clin J Med, 2002,69( suppl 1 ) : SI31-39.
  • 6Leese, Philip T. Valdecoxib does not impair platelet function. Am J Emerg Meal, 2002,20(4) : 275-281.
  • 7Bingham, Clifton O. Development and clinical application of COX-2-selective inhibitors for the treatment of osteoarthritis and rheumatics arthritis. Cleve Clin J Med,2002,69(suppl 1 ):SI5-12.
  • 8Tanaka A, Araki H. Up-regulation of COX-2 by inhibitor of COX-1 in the rat: akey to NSAIDs induced gastric injury. Aliment Pharmacol Ther, 2002,16(suppl2) :90-101.
  • 9Qi Zhonghua, Hao Chuannfing. Opposite effects of COX-1 and -1 activity on the pressor response to angiotensin Ⅱ. J Clin Invest,2002,110(1) :61-69.
  • 10Anonymous. Renal impairment due to topical NSAIDs. Prescrire Im,2002,11(59) :86.

同被引文献20

  • 1夏文广,安长青,郑婵娟,张继先,黄敏,王喻,杨丰文,段璨,李正良,刘清泉,张伯礼.中西医结合治疗新型冠状病毒肺炎34例临床研究[J].中医杂志,2020,61(5):375-382. 被引量:268
  • 2黄秀芳,高元兴,金建国,张圣塨.氯诺昔康用于电视胸腔镜手术病人超前镇痛的临床观察[J].浙江临床医学,2006,8(4):409-409. 被引量:5
  • 3[1]Skjodt NM,Davies NM.Clinical pharmacokinetics of lornoxicam.A short half-time oxicam[J].Clin Pharmacokinetic,1998,34(2):421
  • 4[3]Kehlet H,Werner M,Perkins F.Balanced analgesia.What is it and what are its advantages in postoperation pain?[J].Drugs,1999,58(6):793
  • 5[7]Code W.NASIDs and balanced analgesia[J].Can J Anaesth,1993,40(5):401
  • 6[8]Kohl C,Steinkellner M.Interaction of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants[J].Drug Metabolism and Disposition,2000,28(1):161
  • 7[9]Norholt S,Sindct S,Bugge C.A randomizcd,doublc-blind,placcbo-controllcd,dosc-rcsponsc study of the analgesic effect of lornoxicam after surgical removal of mandibular third molars[J].Journal of Clinical Pharmacology,1995,35(10):606
  • 8Skjodt NM, Davies NM. Clinical pharmacokinetics of lornoxicam. A short half- time oxicam Clin Phannacokinetic, 1998,34(2) :421.
  • 9Norholt SE, Sindet- Pedersen S, Buqqe C, et al. A randomiled, double blind, placebocouirolled, dose response study of lhe analgesic effect of lornoxicam after surgical removal of mandibular third molars. J Clin Pharmael, 1995,35 : 606 - 614.
  • 10郑艳彬,李雪宁.非甾体抗炎药氯诺昔康[J].国外医药(合成药.生化药.制剂分册),2001,22(3):166-169. 被引量:84

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部